collection
MENU ▼
Read by QxMD icon Read
search

Graves Disease

shared collection
3 papers 0 to 25 followers
By Ehud Ur Professor and Head, Endocrinology, UBC, Vancouver
https://www.readbyqxmd.com/read/27118279/usefulness-of-measuring-thyroid-stimulating-antibody-at-the-time-of-antithyroid-drug-withdrawal-for-predicting-relapse-of-graves-disease
#1
Hyemi Kwon, Won Gu Kim, Eun Kyung Jang, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Jin Sook Ryu, Young Kee Shong, Won Bae Kim
BACKGROUND: Hyperthyroidism relapse in Graves disease after antithyroid drug (ATD) withdrawal is common; however, measuring the thyrotropin receptor antibody (TRAb) at ATD withdrawal in order to predict outcomes is controversial. This study compared measurement of thyroid stimulatory antibody (TSAb) and thyrotropin-binding inhibitory immunoglobulin (TBII) at ATD withdrawal to predict relapse. METHODS: This retrospective study enrolled patients with Graves disease who were treated with ATDs and whose serum thyroid-stimulating hormone levels were normal after receiving low-dose ATDs...
June 2016: Endocrinology and Metabolism
https://www.readbyqxmd.com/read/26863422/predicting-the-risk-of-recurrence-before-the-start-of-antithyroid-drug-therapy-in-patients-with-graves-hyperthyroidism
#2
Xander G Vos, Erik Endert, A H Zwinderman, Jan G P Tijssen, Wilmar M Wiersinga
Genotyping increases the accuracy of a clinical score (based on pretreatment age, goiter size, FT4, TBII) for predicting recurrence of Graves' hyperthyroidism after a course of antithyroid drugs: a prospective study.
April 2016: Journal of Clinical Endocrinology and Metabolism
https://www.readbyqxmd.com/read/25111942/relapse-following-antithyroid-drug-therapy-for-graves-hyperthyroidism
#3
REVIEW
Peter Laurberg, Anne Krejbjerg, Stine Linding Andersen
PURPOSE OF REVIEW: In most patients with hyperthyroidism caused by Graves' disease, antithyroid drug (ATD) therapy is followed by a gradual amelioration of the autoimmune abnormality, but about half of the patients will experience relapse of hyperthyroidism when the ATDs are withdrawn after a standard 1 to 2 years of therapy. This is a major drawback of ATD therapy, and a major concern to patients. We review current knowledge on how to predict and possibly reduce the risk of such relapse...
October 2014: Current Opinion in Endocrinology, Diabetes, and Obesity
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"